(Q44386867)

English

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

José A Pérez-Simón

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Rodrigo Martino

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Adrián Alegre

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

José F Tomás

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Angel De Leon

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dolores Caballero

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ana Sureda

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jordi Sierra

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jesús F San Miguel

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

104-108

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04237.X

21 January 2018

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04237.X

21 January 2018

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04237.X

21 January 2018

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04237.X

21 January 2018

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04237.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2003.04237.X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44386867&oldid=2020771341"